Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Campos, Alline Cristina
Moreira, Fabricio Araújo
Gomes, Felipe Villela
Del Bel, Elaine Aparecida
and
Guimarães, Francisco Silveira
2012.
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders.
Philosophical Transactions of the Royal Society B: Biological Sciences,
Vol. 367,
Issue. 1607,
p.
3364.
Crane, Natania A.
Schuster, Randi Melissa
Fusar-Poli, Paolo
and
Gonzalez, Raul
2013.
Effects of Cannabis on Neurocognitive Functioning: Recent Advances, Neurodevelopmental Influences, and Sex Differences.
Neuropsychology Review,
Vol. 23,
Issue. 2,
p.
117.
Mechoulam, Raphael
and
Parker, Linda
2013.
Towards a better cannabis drug.
British Journal of Pharmacology,
Vol. 170,
Issue. 7,
p.
1363.
van Winkel, Ruud
and
Kuepper, Rebecca
2014.
Epidemiological, Neurobiological, and Genetic Clues to the Mechanisms Linking Cannabis Use to Risk for Nonaffective Psychosis.
Annual Review of Clinical Psychology,
Vol. 10,
Issue. 1,
p.
767.
Lisdahl, Krista M.
Wright, Natasha E.
Medina-Kirchner, Christopher
Maple, Kristin E.
and
Shollenbarger, Skyler
2014.
Considering Cannabis: The Effects of Regular Cannabis Use on Neurocognition in Adolescents and Young Adults.
Current Addiction Reports,
Vol. 1,
Issue. 2,
p.
144.
Bloomfield, Michael A. P.
Morgan, Celia J. A.
Kapur, Shitij
Curran, H. Valerie
and
Howes, Oliver D.
2014.
The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study.
Psychopharmacology,
Vol. 231,
Issue. 11,
p.
2251.
Mechoulam, Raphael
2014.
Cannabinoids.
p.
1.
Freeman, Tom P.
Morgan, Celia J. A.
Hindocha, Chandni
Schafer, Gráinne
Das, Ravi K.
and
Curran, H. Valerie
2014.
Just say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?.
Addiction,
Vol. 109,
Issue. 10,
p.
1686.
Bloomfield, Michael A.P.
Morgan, Celia J.A.
Egerton, Alice
Kapur, Shitij
Curran, H. Valerie
and
Howes, Oliver D.
2014.
Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms.
Biological Psychiatry,
Vol. 75,
Issue. 6,
p.
470.
Iseger, Tabitha A.
and
Bossong, Matthijs G.
2015.
A systematic review of the antipsychotic properties of cannabidiol in humans.
Schizophrenia Research,
Vol. 162,
Issue. 1-3,
p.
153.
Fischer, Benedikt
Kuganesan, Sharan
Gallassi, Andrea
Malcher-Lopes, Renato
van den Brink, Wim
and
Wood, Evan
2015.
Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use.
International Journal of Drug Policy,
Vol. 26,
Issue. 12,
p.
1177.
Freeman, T. P.
and
Winstock, A. R.
2015.
Examining the profile of high-potency cannabis and its association with severity of cannabis dependence.
Psychological Medicine,
Vol. 45,
Issue. 15,
p.
3181.
Zhornitsky, Simon
Tikàsz, Andràs
Rizkallah, Élie
Chiasson, Jean-Pierre
and
Potvin, Stéphane
2015.
Psychopathology in Substance Use Disorder Patients with and without Substance-Induced Psychosis.
Journal of Addiction,
Vol. 2015,
Issue. ,
p.
1.
Hindocha, Chandni
Freeman, Tom P.
Schafer, Grainne
Gardener, Chelsea
Das, Ravi K.
Morgan, Celia J.A.
and
Curran, H. Valerie
2015.
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users.
European Neuropsychopharmacology,
Vol. 25,
Issue. 3,
p.
325.
van Amsterdam, Jan
Brunt, Tibor
and
van den Brink, Wim
2015.
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
Journal of Psychopharmacology,
Vol. 29,
Issue. 3,
p.
254.
Hindocha, Chandni
Shaban, Natacha D.C.
Freeman, Tom P.
Das, Ravi K.
Gale, Grace
Schafer, Grainne
Falconer, Caroline J.
Morgan, Celia J.A.
and
Curran, H. Valerie
2015.
Associations between cigarette smoking and cannabis dependence: A longitudinal study of young cannabis users in the United Kingdom.
Drug and Alcohol Dependence,
Vol. 148,
Issue. ,
p.
165.
Manseau, Marc W.
and
Goff, Donald C.
2015.
Cannabinoids and Schizophrenia: Risks and Therapeutic Potential.
Neurotherapeutics,
Vol. 12,
Issue. 4,
p.
816.
Rohleder, Cathrin
and
Leweke, F. Markus
2015.
Cannabinoids in Neurologic and Mental Disease.
p.
193.
Gage, Suzanne H.
Hickman, Matthew
Heron, Jon
Munafò, Marcus R.
Lewis, Glyn
Macleod, John
Zammit, Stanley
and
Hashimoto, Kenji
2015.
Associations of Cannabis and Cigarette Use with Depression and Anxiety at Age 18: Findings from the Avon Longitudinal Study of Parents and Children.
PLOS ONE,
Vol. 10,
Issue. 4,
p.
e0122896.
Taffe, Michael A
Creehan, Kevin M
and
Vandewater, Sophia A
2015.
Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ9‐tetrahydrocannabinol in Sprague‐Dawley rats.
British Journal of Pharmacology,
Vol. 172,
Issue. 7,
p.
1783.